» Articles » PMID: 33141586

Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2020 Nov 3
PMID 33141586
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

To understand and treat immunology-related diseases, a comprehensive, unbiased characterization of major histocompatibility complex (MHC) peptide ligands is of key importance. Preceding the analysis by mass spectrometry, MHC class I peptide ligands are typically isolated by MHC immunoaffinity chromatography (MHC-IAC) and less often by mild acid elution (MAE). MAE may provide a cheap alternative to MHC-IAC for suspension cells but has been hampered by the high number of contaminating, MHC-unrelated peptides. Here, we optimized MAE, yielding MHC peptide ligand purities of more than 80%. When compared with MHC-IAC, obtained peptides were similar in numbers, identities, and to a large extent intensities, while the percentage of cysteinylated peptides was 5 times higher in MAE. The latter benefitted the discovery of MHC-allotype-specific, distinct cysteinylation frequencies at individual positions of MHC peptide ligands. MAE revealed many MHC ligands with unmodified, N-terminal cysteine residues which get lost in MHC-IAC workflows. The results support the idea that MAE might be particularly valuable for the high-confidence analysis of post-translational modifications by avoiding the exposure of the investigated peptides to enzymes and reactive molecules in the cell lysate. Our improved and carefully documented MAE workflow represents a high-quality, cost-effective alternative to MHC-IAC for suspension cells.

Citing Articles

Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response.

Balakrishnan A, Winiarek G, Holowka O, Godlewski J, Bronisz A Front Immunol. 2025; 16:1540431.

PMID: 39944685 PMC: 11814183. DOI: 10.3389/fimmu.2025.1540431.


Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation.

Juanes-Velasco P, Arias-Hidalgo C, Garcia-Vaquero M, Sotolongo-Ravelo J, Paino T, Lecrevisse Q Int J Mol Sci. 2024; 25(17).

PMID: 39273511 PMC: 11395153. DOI: 10.3390/ijms25179564.


Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens.

Hesnard L, Theriault C, Cahuzac M, Durette C, Vincent K, Hardy M Curr Oncol. 2024; 31(6):3099-3121.

PMID: 38920720 PMC: 11203340. DOI: 10.3390/curroncol31060236.


Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells.

Larson A, Knoche S, Brumfield G, Doty K, Gephart B, Moore-Saufley P Int J Mol Sci. 2024; 25(6).

PMID: 38542184 PMC: 10970070. DOI: 10.3390/ijms25063211.


COSMIC-based mutation database enhances identification efficiency of HLA-I immunopeptidome.

Wang F, Zhang Z, Mao M, Yang Y, Xu P, Lu S J Transl Med. 2024; 22(1):144.

PMID: 38336780 PMC: 10858511. DOI: 10.1186/s12967-023-04821-0.


References
1.
Giam K, Ayala-Perez R, Illing P, Schittenhelm R, Croft N, Purcell A . A comprehensive analysis of peptides presented by HLA-A1. Tissue Antigens. 2015; 85(6):492-6. DOI: 10.1111/tan.12565. View

2.
Saini S, Schuster H, Ramnarayan V, Rammensee H, Stevanovic S, Springer S . Dipeptides catalyze rapid peptide exchange on MHC class I molecules. Proc Natl Acad Sci U S A. 2014; 112(1):202-7. PMC: 4291614. DOI: 10.1073/pnas.1418690112. View

3.
Barnstable C, Bodmer W, Brown G, Galfre G, Milstein C, Williams A . Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 1978; 14(1):9-20. DOI: 10.1016/0092-8674(78)90296-9. View

4.
Andreatta M, Nielsen M . Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics. 2015; 32(4):511-7. PMC: 6402319. DOI: 10.1093/bioinformatics/btv639. View

5.
Bassani-Sternberg M, Pletscher-Frankild S, Jensen L, Mann M . Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol Cell Proteomics. 2015; 14(3):658-73. PMC: 4349985. DOI: 10.1074/mcp.M114.042812. View